Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for September 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Proteins in Human Corneal Epithelial Cells Fight Pathogens
FRIDAY, Sept. 28 (HealthDay News) -- Epithelial cytokeratins constitutively produce cytoprotective antimicrobial peptides and serve as an innate defense mechanism in human corneal epithelial cells, according to a study published online Sept. 24 in the Journal of Clinical Investigation.
Decrease Seen in Global Peri-Op, Anesthesia-Related Mortality
FRIDAY, Sept. 21 (HealthDay News) -- Over the last five decades, there has been a decrease in perioperative and anesthesia-related mortality, according to a study published in the Sept. 22 issue of The Lancet, a theme issue on surgery.
New Vision Test Extends Range of Visual Acuity Measurement
WEDNESDAY, Sept. 12 (HealthDay News) -- The Berkeley Rudimentary Vision Test (BRVT), a simplified visual task, is feasible for measuring visual acuity in patients with severe visual impairment, according to a study published in the September issue of Optometry and Vision Science.
Not All Docs/Nurses Want to Be Asked About Hand Hygiene
FRIDAY, Sept. 7 (HealthDay News) -- Although most health care workers (HCWs) appreciate the role of patients in preventing health care-associated infection, a considerable proportion are uncomfortable with patients asking about their hand hygiene, according to a letter published online Sept. 3 in the Archives of Internal Medicine.
Copyright © 2012 ScoutNews, LLC. All rights reserved.
|Previous: September 2012 Briefing - Hematology & Oncology||Next: September 2012 Briefing - Orthopedics|
Reader comments on this article are listed below. Review our comments policy.